Your browser doesn't support javascript.
loading
Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study.
Botta, Laura; Gatta, Gemma; Capocaccia, Riccardo; Stiller, Charles; Cañete, Adela; Dal Maso, Luigino; Innos, Kaire; Mihor, Ana; Erdmann, Friederike; Spix, Claudia; Lacour, Brigitte; Marcos-Gragera, Rafael; Murray, Deirdre; Rossi, Silvia.
Afiliación
  • Botta L; Evaluative Epidemiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Digestive Cancer Registry of Burgundy, INSERM U1231, University of Bourgogne, Dijon, France. Electronic address: laura.botta@istitutotumori.mi.it.
  • Gatta G; Evaluative Epidemiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Capocaccia R; Editorial board, Epidemiologia e Prevenzione, Milan, Italy.
  • Stiller C; National Disease Registration Service, NHS Digital, London, UK.
  • Cañete A; Spanish Registry of Childhood Tumours, University of Valencia, Valencia, Spain; Department of Paediatrics, University of Valencia, Valencia, Spain.
  • Dal Maso L; Cancer Epidemiology Unit, Centro di Riferimento Oncologico (CRO) IRCCS, Aviano, Italy.
  • Innos K; Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia.
  • Mihor A; Epidemiology and Cancer Registry, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • Erdmann F; Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Spix C; Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Lacour B; French National Registry of Childhood Solid Tumors, CHU Nancy, Vandœuvre-lès-Nancy, France; Inserm UMRS-1153, CRESS team 7, University of Paris Cité, Paris, France.
  • Marcos-Gragera R; Epidemiology Unit and Girona Cancer Registry, Department of Health, Catalan Institute of Oncology, Girona Biomedical Research Institute, Girona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain; Josep Carreras Leukemia Research Institute, Girona, Spain.
  • Murray D; National Cancer Registry Ireland, Cork, Ireland; School of Public Health, University College Cork, Cork, Ireland.
  • Rossi S; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Lancet Oncol ; 23(12): 1525-1536, 2022 12.
Article en En | MEDLINE | ID: mdl-36400102
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Retinoblastoma / Sarcoma de Ewing / Neoplasias Óseas / Linfoma de Burkitt / Neoplasias de la Retina Tipo de estudio: Prognostic_studies Límite: Child / Humans País/Región como asunto: Europa Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Retinoblastoma / Sarcoma de Ewing / Neoplasias Óseas / Linfoma de Burkitt / Neoplasias de la Retina Tipo de estudio: Prognostic_studies Límite: Child / Humans País/Región como asunto: Europa Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article